Publisher: GlobalData
Category: Pharmaceuticals

Pharmaceuticals market research reports by GlobalData

(1,998 reports matching your criteria)
    • Sickle Cell Disease - Global Clinical Trials Review, 2025

      Sickle Cell Disease - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Sickle Cell Disease - Global Clinical Trials Review, 2025 provides an overview of Sickle Cell Disease Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More

    • Endometriosis - Global Clinical Trials Review, 2025

      Endometriosis - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Endometriosis - Global Clinical Trials Review, 2025 provides an overview of Endometriosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Endometriosis. Re ... Read More

    • Hypoglycemia - Global Clinical Trials Review, 2025

      Hypoglycemia - Global Clinical Trials Review, 2025 Summary GlobalData's clinical trial report, “Hypoglycemia - Global Clinical Trials Review, 2025 provides an overview of Hypoglycemia Clinical trials scenario. This report provides top line data relating to the clinical trials on Hypoglycemia. Report ... Read More

    • Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review

      Pfizer Inc (PFE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the ... Read More

    • Ache Laboratorios Farmaceuticos SA - Strategic SWOT Analysis Review

      Ache Laboratorios Farmaceuticos SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major ... Read More

    • Unilab Inc - Strategic SWOT Analysis Review

      Unilab Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T ... Read More

    • SANOCHEMIA Pharmazeutika GmbH - Strategic SWOT Analysis Review

      SANOCHEMIA Pharmazeutika GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ ... Read More

    • Eurofarma Laboratorios SA - Strategic SWOT Analysis Review

      Eurofarma Laboratorios SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products ... Read More

    • WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review

      WEX Pharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an ... Read More

    • Mucopolysaccharidosis I (MPS I) (Hurler syndrome): Market View

      Mucopolysaccharidosis I (MPS I) (Hurler syndrome): Market View Summary This reports provides a data-driven overview of the current and future competitive landscape in Mucopolysaccharidosis I (Hurler syndrome) Therapeutics. In 2024, there were more than 1,740 diagnosed prevalent cases of MPS I in the ... Read More

    • Strategic Intelligence: Healthcare M&A Deals Q1 2025 - Top Themes

      Strategic Intelligence: Healthcare M&A Deals Q1 2025 - Top Themes Summary This report analyzes the disruptive themes that have driven M&A activity in Q1 2025 in the Healthcare Sector. The global healthcare market in Q1 2025 witnessed deals worth $91 billion, a decline of 10% compared to Q1 2024. The ... Read More

    • Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review

      Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea ... Read More

    • Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review

      Cyclacel Pharmaceuticals Inc (CYCC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review

      Cumberland Pharmaceuticals Inc (CPIX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an ... Read More

    • Stada Arzneimittel AG - Strategic SWOT Analysis Review

      Stada Arzneimittel AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ... Read More

    • Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review

      Madrigal Pharmaceuticals Inc (MDGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and ... Read More

    • Strategic Intelligence: The Internet of Things in Healthcare (2025)

      Strategic Intelligence: The Internet of Things in Healthcare (2025) Summary The Internet of Things (IoT) describes the use of connected sensors and actuators to control and monitor the environment, the things that move within it, and the people that act within it. In healthcare, IoT devices are vita ... Read More

    • Dermatomyositis (DM): Market View

      Dermatomyositis (DM): Market View Summary This reports provides a data-driven overview of the current and future competitive landscape in Dermatomyositis Therapeutics. GlobalData epidemiologists estimate that there were 791,779 diagnosed prevalent cases of Dermatomyositis (DM) in 2024, which is expe ... Read More

    • Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036

      Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 Summary Colorectal Cancer Screening Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2036 is built to visualize quantitative and qualitative market trends ... Read More

    • AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review

      AbbVie Inc (ABBV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the ... Read More

    • Bio/Pharmaceutical Outsourcing Report, April 2025

      Bio/Pharmaceutical Outsourcing Report, April 2025 Summary The Bio/Pharmaceutical Outsourcing Report is a monthly analysis of news and trends affecting pharmaceutical Contract Manufacturing Organizations (CMOs). It includes in-depth analyses of the latest business conditions, lists new outsourcing co ... Read More

    • Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review

      Oramed Pharmaceuticals Inc (ORMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we ... Read More

    • Traws Pharma Inc (TRAW) - Financial and Strategic SWOT Analysis Review

      Traws Pharma Inc (TRAW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a ... Read More

    • GLP-1R Agonists – Label Extensions/Drug Repurposing: Market Overview

      GLP-1R Agonists – Label Extensions/Drug Repurposing: Market Overview Summary This report is a market overview of GLP-1R agonists, focusing on their potential repurposing and label expansions in diseases outside type 2 diabetes and obesity. The potential of GLP-1RAs is based on their insulin sensitiz ... Read More

    • Opportunities in the Global Vitamins and Dietary Supplements Sector 2025

      Opportunities in the Global Vitamins and Dietary Supplements Sector 2025 Summary The global vitamins and dietary supplements sector was valued at $138.2 billion in 2024 and will reach $188.7 billion in 2029, at a compound annual growth rate (CAGR) of 6.4%. Thanks to the popularity of supplements in ... Read More

1 2 3 4 5 6 7 8 9 10

Cookie Settings